Further results from ENGAGE trial of Edoxaban published

The current issue of The Lancet (09/06/15) contains 2 articles concerned with the results of the ENGAGE-AF trial of Edoxaban, a Factor Xa inhibitor, for use in patients in AF.

Click to link: A subscription or library access is required